FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients. (October 2021)

• Record Type: Journal Article
• Authors: Awano, Hiroyuki; Saito, Yoshihiko; Shimizu, Mamiko; Sekiguchi, Kenji; Niijima, Shinichi; Matsuo, Masafumi; Maegaki, Yoshihiro; Izumi, Isho; Kikuchi, Chiya; Ishibashi, Masato; Okazaki, Tetsuya; Komaki, Hirofumi; Iijima, Kazumoto; Nishino, Ichizo
• Is Part Of: Journal of clinical neuroscience. Volume 92(2021)
• Page Start: 215
• Page End: 221
• Publication Date: 2021-10
• Subjects: Fukutin-related protein -- Alpha-dystroglycanopathies -- Congenital muscular dystrophy type 1C -- Limb-girdle muscular dystrophy 2I; Brain -- Surgery -- Periodicals; Neurosciences -- Periodicals; Nervous system -- Surgery -- Periodicals; Brain -- surgery -- Periodicals; Neurosurgical Procedures -- Periodicals; Neurosciences -- Periodicals; Electronic journals; 616.8
• DOI: 10.1016/j.jocn.2021.08.014
• Languages: English
• ISSNs: 0967-5868

Abstract

Highlights: FKRP mutations caused MDC1C and LGMD2I, but not severe forms, in Asian patients. Five novel FKRP mutations were identified in our Asian cohort. No common FKRP mutation was observed in Asian patients. Abstract: Mutation in the fukutin-related protein (FKRP) gene causes alpha-dystroglycanopathies, a group of autosomal recessive disorders associated with defective glycosylated alpha-dystroglycan (α-DG). The disease phenotype shows a broad spectrum, from the most severe congenital form involving brain and eye anomalies to milder limb-girdle form. FKRP -related alpha-dystroglycanopathies are common in European countries. However, a limited number of patients have been reported in Asian countries. Here, we presented the clinical, pathological, and genetic findings of nine patients with FKRP mutations identified at a single muscle repository center in Japan. Three and six patients were diagnosed with congenital muscular dystrophy type 1C and limb-girdle muscular dystrophy 2I, respectively. None of our Asian patients showed the most severe form of alpha-dystroglycanopathy. While all patients showed a reduction in glycosylated α-DG levels, to variable degrees, these levels did not correlate to clinical severity. Fifteen distinct pathogenic mutations were identified in our cohort, including five novel mutations. Unlike in the populations belonging to European countries, no common mutation was found in our cohort.